{"editorial":{"content_id":"2df89675-c636-4b6e-a757-8a39cfacf0cc","slug":"eurofarma-20261022-3abca1","content_type":"news","title":"Eurofarma因商业原因暂时停产唑吡坦仿制药","summary":"巴西制药企业Eurofarma以商业原因为由，暂时停止生产半酒石酸唑吡坦仿制药。","body":"巴西制药企业Eurofarma宣布暂时停止生产半酒石酸唑吡坦（zolpidem）仿制药。据该公司公告，这一决定是出于商业原因。\n\n该缓释药物在巴西国家卫生监督局（Anvisa）的注册号为100431479，以6.25毫克和12.5毫克两种剂量的包衣片剂形式销售。\n\nEurofarma表示，市场上存在可用的替代治疗方案，并建议患者咨询医生，以了解可能的替代用药。公司还提示可通过EuroAtende服务获取更多信息，电话为0800 704 3876，邮箱为euroatende@eurofarma.com。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["企业动态","行业趋势","br-health"],"content_level":"编辑整理","event_type":"公司动态","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-10-22T11:02:43.607Z","display_date":"2026-10-22","source_published_at":null,"source_url":"https://panoramafarmaceutico.com.br/eurofarma-suspende-temporariamente-fabricacao-de-zolpidem-generico/","source_name":"Panorama Farmacêutico","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":["supply_risk"],"opportunity_flags":[],"trend_signals":[]},"intelligence":{"intel_id":"6263afa7-67c5-4816-9990-e2678787dd38","version":1,"event_type":"风险事件","event_date":null,"main_entities":[{"name":"Eurofarma","role":"宣布暂时停产半酒石酸唑吡坦仿制药的巴西制药企业","type":"company","country":"巴西","normalized_name":null},{"name":"半酒石酸唑吡坦仿制药","role":"被暂时停止生产的缓释仿制药产品","type":"product","country":"巴西","normalized_name":null},{"name":"Anvisa","role":"该药品注册监管机构","type":"regulator","country":"巴西","normalized_name":null}],"main_action":"Eurofarma因商业原因暂时停产唑吡坦仿制药","key_numbers":[{"unit":"注册号","label":"Anvisa注册号","value":"100431479"},{"unit":"mg","label":"剂量1","value":"6.25"},{"unit":"mg","label":"剂量2","value":"12.5"}],"facts":[{"verified":false,"statement":"Eurofarma宣布暂时停止生产半酒石酸唑吡坦仿制药，并称决定出于商业原因。","source_excerpt":null},{"verified":false,"statement":"该缓释药物在Anvisa的注册号为100431479，以6.25毫克和12.5毫克包衣片剂形式销售。","source_excerpt":null},{"verified":false,"statement":"Eurofarma表示市场存在可用替代治疗方案，并建议患者咨询医生；公司提供EuroAtende电话0800 704 3876和邮箱euroatende@eurofarma.com。","source_excerpt":null}],"assessments":[{"statement":"停产为临时性且归因于商业原因，暂未见安全或疗效问题，但可能造成该仿制药短期供应波动。","confidence":"medium","basis_fact_index":null},{"statement":"因公司称存在替代治疗方案，患者治疗中断风险可能有限，但仍需医生评估后调整用药。","confidence":"medium","basis_fact_index":null},{"statement":"当前信息来自单一来源，需关注Anvisa注册状态及停产持续时间。","confidence":"medium","basis_fact_index":null}],"actions":[{"target":"both","priority":"high","description":"跟踪Anvisa注册状态及Eurofarma后续公告，确认停产期限和供应恢复计划。"},{"target":"user","priority":"normal","description":"核实6.25毫克和12.5毫克唑吡坦替代药品在巴西市场的可及性和库存。"},{"target":"user","priority":"normal","description":"提示患者和处方医生咨询医生调整用药，不自行停药。"}],"affected_audience":["使用半酒石酸唑吡坦仿制药的患者","处方医生","药房和药品经销商"],"risk_flags":["supply_risk"],"opportunity_flags":[],"trend_signals":[],"follow_up_needed":true,"follow_up_questions":["此次停产预计持续多久，恢复生产的条件是什么？","Anvisa注册号100431479当前状态是否仍有效？","6.25毫克和12.5毫克剂型的替代药品在巴西市场供应是否充足？"],"related_topics":["唑吡坦","仿制药","Eurofarma","Anvisa","药品供应","失眠治疗"],"verification_status":"unverified","confidence_score":0.7,"generated_at":"2026-10-22T11:02:56.714Z"},"meta":{"canonical_url":"https://chinabrazilinsight.com/news/eurofarma-20261022-3abca1","api_url":"https://chinabrazilinsight.com/api/public/content/eurofarma-20261022-3abca1","markdown_url":"https://chinabrazilinsight.com/api/public/content/eurofarma-20261022-3abca1?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/eurofarma-20261022-3abca1?view=json","last_updated":"2026-10-22T11:02:56.858Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}